Key Record Dates
ClinicalTrials.gov Identifier: | NCT02631070 |
---|---|
Brief Title: | A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MEDALIST) |
First Submitted : | November 10, 2015 |
First Submitted that Met QC Criteria : | December 11, 2015 |
First Posted : | December 15, 2015 (Estimate) |
Results First Submitted : | May 1, 2020 |
Results First Submitted that Met QC Criteria : | May 1, 2020 |
Results First Posted : | May 22, 2020 |
Certification/Extension First Submitted : | May 16, 2018 |
Certification/Extension First Submitted that Met QC Criteria : | May 16, 2018 |
Certification/Extension First Posted : | May 18, 2018 |
Last Update Submitted that Met QC Criteria : | November 19, 2021 |
Last Update Posted : | December 17, 2021 |